Category Archives: Alternative Medicine

31 January 2022

Director of the Progress Educational Trust and commissioning editor of its flagship publication BioNews

There has been much professional and public debate about the use of so-called fertility treatment 'add-ons' over the years. The Progress Educational Trust's event 'Adding Up What We Know: A Global Perspective on Fertility Treatment Add-Ons' brought together an international lineup of speakers to share their knowledge and broaden the discussion.

Dr Kersti Lundin director of Sahlgrenska University Hospital's Reproductive Medicine Laboratory, and co-chair of the European Society for Human Reproduction and Embryology (ESHRE)'s working group on add-ons opened the discussion by setting out what add-ons are. They are something 'not essential for treatment, but optional interventions added on top, most often at an additional cost' she said.

Dr Lundin explained that there are a wide range of treatment add-ons on offer; including different tests, drugs, holistic or alternative therapies, 'special' equipment, laboratory techniques and surgical interventions. It is claimed that these improve pregnancy or live birth rates, reduce the risk of miscarriage, or shorten the time to pregnancy.

ESHRE has set up a working group to produce recommendations for professionals, patients and policymakers, with the aim of ensuring that all fertility patients receive safe and evidence-based treatment. Some 33 add-ons have been identified and stratified into different categories diagnostic tests, laboratory interventions, clinical management and 'selective' add-ons. Dr Lundin said that 'selective' add-ons were treatments which are clinically appropriate for some patients for example, intracytoplasmic sperm injection (ICSI) for male factor fertility which should not be used for all patients.

The next panellist was Dr Manuela Perotta, a senior lecturer in technology and organisation at Queen Mary University of London and principal investigator at the Remaking the Human Body project (which is funded by Wellcome). Dr Perotta presented some of the findings from this project.

Anyone still in any doubt about the proliferation of add-ons would have those doubts pushed aside on hearing the results of a survey that Dr Perrotta and her team had carried out. Patients reported on the add-ons they had used, been offered or considered using. She showed a very busy word cloud which listed around 60 procedures believed by some to be add-ons, ranging from endometrial scratch to DNA karyotyping.

The focus of Dr Perrotta's talk was differences in perceptions of add-ons between professionals, patients and patients' partners. Some professionals considered something to be an add-on depending on whether and how it was itemised on the bill given to a paying patient, while others thought there should be distinctions as to how an add-on was regulated depending on how invasive the particular treatment was.

There were very wide-ranging findings when it came to patients' perceptions. Some patients extensively researched add-ons and sought them out, while others wanted to delegate decisions about their treatment including add-ons to the medical professionals. The postcode lottery relating to state funding of fertility treatment leads to some NHS patients being treated in private clinics and some self-funded patients being treated in NHS clinics, making it yet more difficult to decide what is and isn't an add-on in the UK. Furthermore, if a patient has only a very limited opportunity for state-funded treatment, then they are understandably liable to try everything possible to help the treatment work.

Dr Perrotta discussed the Human Fertilisation and Embryology Authority (HFEA)'s traffic light system for assessing add-ons. Her research had uncovered a number of issues for patients with the current system perhaps most significantly, the fact that many of them are not aware of it. Other patients did find the HFEA's information during the course of their extensive online research, but even then, they did not necessarily feel equipped to evaluate the advisability of add-ons in their specific situation.

Dr Perrotta argued that the HFEA's traffic lights need to be more visible, need to present information about other relevant criteria besides live birth rates (for example, of miscarriage rates) and should make it possible for patients to explore multiple layers of information about evidence.

We moved from the UK to Australasia with the next speaker, Dr Sarah Lensen an editor at Cochrane's Gynaecology and Fertility Group, where she was responsible for the Cochrane Special Collection 'IVF: Effectiveness of Add-Ons and Research', and also a research fellow at the University of Melbourne. Australia has one of the highest uses of IVF per capita in the world, with just over 2600 cycles per million per year being carried out. There is however, little data relating to add-ons from the Australia and New Zealand Assisted Reproduction Database.

Dr Lensen and her team investigated the add-ons by assessing clinic websites in Australia and New Zealand, and found that 78 percent of clinic websites offered add-ons. There were 21 different add-ons on offer (using these researchers' definition of an add-on), the cost of which ranged from no extra charge to around 2000. PGT-A, time lapse and assisted hatching were the add-ons most commonly listed, and most descriptions of add-ons contained statements about the add-ons' supposed benefits.

A patient survey relating to the prevalence, offer and use of add-ons was then carried out. There were 1600 responses, and 82 percent of respondents had used an add-on. The most commonly used add-on was acupuncture specifically intended to accompany fertility treatment (see BioNews 1107), followed by PGT-A and Chinese herbal medicine. Most people who had used an add-on had heard about it from their fertility specialist, who raised it during a consultation.

Dr Lensen concluded her presentation with some interesting research on the use of endometrial scratch. In 2015, her team found that 83 percent of clinicians offered endometrial scratch, with 73 percent believing it to be beneficial for recurrent implantation failure. During the intervening years, the use of endometrial scratch has not been backed up by evidence. Research carried out in 2020 showed that only 34 percent were now offering this treatment, with 24 percent believing it to be beneficial (see BioNews 1126).

Back to Europe for the next speaker, Satu Rautakallio-Hokkanen, who is chair of Fertility Europe (an umbrella group of 26 fertility patient organisations) and also secretary of Infertility Association Simpukka (which is based in Finland). She gave the all-important patient perspective, which is key to understanding the use and prevalence of add-ons. We learned how despair, ignorance and desperation for information feed into the uptake of add-ons. Rautakallio-Hokkanen and colleagues had conducted a survey which found that 55 percent of patients found out about add-ons from the internet, and 93 percent wanted to find out more about them. The main driver, she suggested, is that add-ons provide hope.

Worryingly, 49 percent stated that they didn't know or didn't understand the benefits of the relevant add-on, but still wanted to try it. More worryingly still, 65 percent could not say whether they thought the add-on was safe or not. Rautakallio-Hokkanen called for more respect to be shown to patients and an end to the exploitation of their despair. Patients need proven treatments and an honest discussion about the risks and benefits, she said.

Next we hopped over the pond to the USA, to hear from Dr Sigal Klipstein chair of the American Society for Reproductive Medicine (ASRM)'s Ethics Committee, and an obstetrician/gynaecologist at InVia Fertility in Chicago.

Dr Klipstein outlined the recent publication Moving Innovation to Practice, in which the ASRM Ethics Committee emphasises that evidence of safety and effectiveness is necessary, before dissemination of new interventions into clinical practice. Dr Klipstein said that the key question for patients should be 'Will this particular treatment benefit me?'. She said that some patients feel lucky to stumble upon the only clinic that offers 'treatment X', but they should question this if treatment X is so great, why aren't more clinics offering it? She used an amusing made-up study to illustrate how easily studies can be skewed by small sample sizes and cherrypicking patient groups.

Dr Klipstein concluded by challenging the audience with a series of fundamental questions. If a patient asks for an add-on and is willing to pay, and their doctor acquiesces, is this acquiescence tantamount to implicit approval? Does it give false hope or? Conversely, if the doctor declines to offer the requested treatment, is this paternalistic? Or is it actually good medical care?

The final speaker was Peter Thompson, chief executive of the HFEA. He welcomed the fact that there is now more global discussion of add-ons than was previously the case, with different professional bodies taking an interest. What the HFEA aims to do, he said, is to provide impartial and independent evidence and information on add-ons for professionals and patients. One of the major challenges has been how to explain complex and subtle issues in a simple but meaningful way, such that it is accessible.

The HFEA's current traffic light system rates 11 add-ons, and assesses add-ons according to one key criterion - is the treatment under consideration proven to be effective, for most fertility patients, in increasing their chances of having a baby?

The HFEA is looking at reviewing and refining the traffic light system, and will be carrying out a consultation on this in future. As there are currently no 'green' rated add-ons listed on the HFEA website, this may lead some patients to view an 'amber' rating as a recommendation, rather than (as is intended) a warning to be cautious. So perhaps changes in presentation are warranted. Another area that Thompson mentioned reviewing was the evidence base used for the rating system - this relies on randomised controlled trials, which is arguably problematic when there is a dearth of such trials. The final consideration is whether to change the measure of success from improving the live birth rate to reducing miscarriage, or reducing time to pregnancy.

After these opening presentations, the audience asked questions about whether and when ICSI should be considered an add-on, a lack of awareness among patients of the risks posed by some add-ons, and the fact that some patients are not even aware that they are using an add-on. There was clear agreement among the speakers that it should not be the responsibility of the patient to ask about risks.

One of the main take-home messages was the need for shared decision-making, so that while patients' voices are heard and taken into account, doctors do not abrogate their responsibility. Fertility doctors must be prepared to give patients unpalatable advice, about why certain treatments may not be appropriate.

PET is grateful to the team at the Remaking the Human Body project (which is based at Queen Mary University of London and funded by Wellcome) for supporting this event. Our next online events will be:

Go here to read the rest:

Adding Up What We Know: A Global Perspective on Fertility Treatment Add-Ons - BioNews

Completed first phase of contract for $50 million; HHS options to procure up to $31 million of ANTHIM by the first half of 2023

Reaffirms ANTHIM as an important medical countermeasure in the U.S. governments strategy to maintain sufficient quantities of anthrax anti-toxin to effectively respond to an anthrax emergency

PARSIPPANY, N.J., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Elusys Therapeutics, Inc. (Elusys) announced today that it has finalized a contract with the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) for the continued supply of ANTHIM (obiltoxaximab), an anthrax antitoxin, for use against a potential anthrax attack.

Elusys is pleased to continue its successful track record of supplying a critical medicine to treat the deadly effects of anthrax exposure, said Elizabeth Posillico, president and chief executive officer of Elusys. ANTHIM is a key therapeutic in the U.S. governments preparedness strategy to protect the U.S. population against natural and man-made biothreats.

The contract for the procurement of ANTHIM consists of a base period of performance, valued at $50 million, which has been fulfilled. The contract includes options valued up to $31 million. If all options are exercised, the total contract value will be $80,864,000 with completion of the contract expected by the first half of 2023. Contract 75A50121C00073 is funded by HHS ASPR.

As previously announced, Elusys has executed a definitive merger agreement with Heat Biologics, Inc. (NASDAQ: HTBX), pursuant to which Elusys will merge into a wholly owned subsidiary of Heat. The acquisition is expected to close during the first quarter of 2022 and is subject to customary closing conditions.

About ANTHIMANTHIM is a monoclonal antibody that binds to the protective antigen (PA) component of anthrax toxin. ANTHIMs toxin neutralizing activity prevents entry of anthrax toxin into susceptible cells, avoiding further spread of the toxin throughout the body and the ensuing tissue damage that leads to death. ANTHIM is supplied as single-dose vials for IV infusion.

Story continues

ANTHIM is indicated in adult and pediatric patients for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate. ANTHIM should only be used for prophylaxis when its benefit for prevention of inhalational anthrax outweighs the risk of hypersensitivity and anaphylaxis. The effectiveness of ANTHIM is based solely on efficacy studies in animal models of inhalational anthrax. There have been no studies of the safety or pharmacokinetics (PK) of ANTHIM in the pediatric population. Dosing in pediatric patients was derived using a population PK approach. ANTHIM does not have direct antibacterial activity. ANTHIM should be used in combination with appropriate antibacterial drugs. ANTHIM is not expected to cross the blood-brain barrier and does not prevent or treat meningitis.

Anthrax is a life-threatening infectious disease caused by Bacillus anthracis. Cases of inhalational anthrax in humans can occur through intentional spread of B. anthracis spores as a biowarfare or bioterrorism agent. B. anthracis spores introduced through the lungs lead to inhalational anthrax, which is deadly in humans.

IMPORTANT SAFETY INFORMATION Including BOXED WARNING

WARNING: HYPERSENSITIVITY and ANAPHYLAXISHypersensitivity reactions, including anaphylaxis, have been reported during ANTHIM infusion. ANTHIM should be administered in monitored settings by personnel trained and equipped to manage anaphylaxis. Stop ANTHIM infusion immediately and treat appropriately if hypersensitivity or anaphylaxis occurs.

WARNINGS AND PRECAUTIONSHypersensitivity and anaphylaxis have been reported during the IV infusion of ANTHIM. Due to the risk of hypersensitivity and anaphylaxis, ANTHIM should be administered in monitored settings by personnel trained and equipped to manage anaphylaxis. Monitor individuals who receive ANTHIM closely for signs and symptoms of hypersensitivity reactions throughout the infusion and for a period of time after administration. Stop ANTHIM infusion immediately and treat appropriately if hypersensitivity or anaphylaxis occurs. Pre-medication with diphenhydramine is recommended prior to administration of ANTHIM. Diphenhydramine pre-medication does not prevent anaphylaxis and may mask or delay onset of symptoms of hypersensitivity.

ADVERSE REACTIONS The safety of ANTHIM has been studied only in healthy volunteers. It has not been studied in patients with inhalational anthrax. The most frequently reported adverse reactions were headache, pruritus, infections of the upper respiratory tract, cough, vessel puncture site bruise, infusion site swelling, urticaria, nasal congestion, infusion site pain, and pain in extremity.

USE IN SPECIFIC POPULATIONSPediatric Use: There have been no studies of the safety or PK of ANTHIM in the pediatric population.

To see the complete prescribing information for ANTHIM, click here.

About Elusys Therapeutics Elusys, based in Parsippany, NJ, is focused on the development of antibody therapeutics for the treatment of infectious disease. ANTHIM(obiltoxaximab) Injection, the companys monoclonal antibody (mAb) anthrax antitoxin, received market clearance by the U.S. Food and Drug Administration (FDA) in March 2016. In July 2020, Health Canada approved ANTHIMs New Drug Submission (NDS) for the treatment of inhalation anthrax. ANTHIM has also received marketing approved in the E.U. and the U.K., under the trade name of Obiltoxaximab SFL. For more information, please visit http://www.elusys.com.

CONTACT: Elizabeth PosillicoElusys Therapeutics, Inc.t: 973.808.0222e: eposillico@elusys.com

Go here to read the rest:

Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human...

Chris Howe, the founder of The Voice of Healing, is offering the Healing Handprint for free to bring positive life transformations.

Chris Howe, an experienced alternative healer and the founder of The Voice of Healing, announced that hes giving free Absent Healing using the Power of the Healing Hand. Interested parties can download the healing handprint at Chriss website, place their hand on the print for 15 minutes every day, and experience positive mental and physical transformations.

Absent Healing is a form of ancient alternative medicine centred on restoring health by non-physical means. The idea is to restore the balance in the mind, body, and soul and remove the blockages in ones energy field.

Using the healing handprint as a medium, Chris can connect with anyone around the world and send his healing energy to restore the free flow of energy in ones body, starting the process of self-healing. The right handprint delivers positive energy, while the left handprint draws negative energy.

Chriss Healing Hand has had over 2 million downloads since its initial launch. Many experienced improved physical and mental health, some of whom had their ailments healed or gone without a trace.

Those healing handprints really made a difference.

The tumour completely disappeared a change doctors could only put down to Chris.

Interested individuals can connect with Chris Howe and learn more about absent healing and alternative therapy here:https://www.thevoiceofhealing.co.uk.

Media ContactCompany Name: The Voice of HealingContact Person: Christopher HoweEmail: Send EmailPhone: +44 7774817513Country: United KingdomWebsite: https://www.thevoiceofhealing.co.uk/

See original here:

The Voice of Healing Brings Back the Healing Handprint to the Web - Digital Journal

Completed first phase of contract for $50 million; HHS options to procure up to $31 million of ANTHIM by the first half of 2023

Reaffirms ANTHIM as an important medical countermeasure in the U.S. governments strategy to maintain sufficient quantities of anthrax anti-toxin to effectively respond to an anthrax emergency

PARSIPPANY, N.J., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Elusys Therapeutics, Inc. (Elusys) announced today that it has finalized a contract with the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) for the continued supply of ANTHIM (obiltoxaximab), an anthrax antitoxin, for use against a potential anthrax attack.

Elusys is pleased to continue its successful track record of supplying a critical medicine to treat the deadly effects of anthrax exposure, said Elizabeth Posillico, president and chief executive officer of Elusys. ANTHIM is a key therapeutic in the U.S. governments preparedness strategy to protect the U.S. population against natural and man-made biothreats.

The contract for the procurement of ANTHIM consists of a base period of performance, valued at $50 million, which has been fulfilled. The contract includes options valued up to $31 million. If all options are exercised, the total contract value will be $80,864,000 with completion of the contract expected by the first half of 2023. Contract 75A50121C00073 is funded by HHS ASPR.

As previously announced, Elusys has executed a definitive merger agreement with Heat Biologics, Inc. (NASDAQ: HTBX), pursuant to which Elusys will merge into a wholly owned subsidiary of Heat. The acquisition is expected to close during the first quarter of 2022 and is subject to customary closing conditions.

About ANTHIMANTHIM is a monoclonal antibody that binds to the protective antigen (PA) component of anthrax toxin. ANTHIMs toxin neutralizing activity prevents entry of anthrax toxin into susceptible cells, avoiding further spread of the toxin throughout the body and the ensuing tissue damage that leads to death. ANTHIM is supplied as single-dose vials for IV infusion.

ANTHIM is indicated in adult and pediatric patients for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate. ANTHIM should only be used for prophylaxis when its benefit for prevention of inhalational anthrax outweighs the risk of hypersensitivity and anaphylaxis. The effectiveness of ANTHIM is based solely on efficacy studies in animal models of inhalational anthrax. There have been no studies of the safety or pharmacokinetics (PK) of ANTHIM in the pediatric population. Dosing in pediatric patients was derived using a population PK approach. ANTHIM does not have direct antibacterial activity. ANTHIM should be used in combination with appropriate antibacterial drugs. ANTHIM is not expected to cross the blood-brain barrier and does not prevent or treat meningitis.

Anthrax is a life-threatening infectious disease caused by Bacillus anthracis. Cases of inhalational anthrax in humans can occur through intentional spread of B. anthracis spores as a biowarfare or bioterrorism agent. B. anthracis spores introduced through the lungs lead to inhalational anthrax, which is deadly in humans.

IMPORTANT SAFETY INFORMATION Including BOXED WARNING

WARNING: HYPERSENSITIVITY and ANAPHYLAXISHypersensitivity reactions, including anaphylaxis, have been reported during ANTHIM infusion. ANTHIM should be administered in monitored settings by personnel trained and equipped to manage anaphylaxis. Stop ANTHIM infusion immediately and treat appropriately if hypersensitivity or anaphylaxis occurs.

WARNINGS AND PRECAUTIONSHypersensitivity and anaphylaxis have been reported during the IV infusion of ANTHIM. Due to the risk of hypersensitivity and anaphylaxis, ANTHIM should be administered in monitored settings by personnel trained and equipped to manage anaphylaxis. Monitor individuals who receive ANTHIM closely for signs and symptoms of hypersensitivity reactions throughout the infusion and for a period of time after administration. Stop ANTHIM infusion immediately and treat appropriately if hypersensitivity or anaphylaxis occurs. Pre-medication with diphenhydramine is recommended prior to administration of ANTHIM. Diphenhydramine pre-medication does not prevent anaphylaxis and may mask or delay onset of symptoms of hypersensitivity.

ADVERSE REACTIONS The safety of ANTHIM has been studied only in healthy volunteers. It has not been studied in patients with inhalational anthrax. The most frequently reported adverse reactions were headache, pruritus, infections of the upper respiratory tract, cough, vessel puncture site bruise, infusion site swelling, urticaria, nasal congestion, infusion site pain, and pain in extremity.

USE IN SPECIFIC POPULATIONSPediatric Use: There have been no studies of the safety or PK of ANTHIM in the pediatric population.

To see the complete prescribing information for ANTHIM, click here.

About Elusys Therapeutics Elusys, based in Parsippany, NJ, is focused on the development of antibody therapeutics for the treatment of infectious disease. ANTHIM(obiltoxaximab) Injection, the companys monoclonal antibody (mAb) anthrax antitoxin, received market clearance by the U.S. Food and Drug Administration (FDA) in March 2016. In July 2020, Health Canada approved ANTHIMs New Drug Submission (NDS) for the treatment of inhalation anthrax. ANTHIM has also received marketing approved in the E.U. and the U.K., under the trade name of Obiltoxaximab SFL. For more information, please visitwww.elusys.com.

CONTACT: Elizabeth PosillicoElusys Therapeutics, Inc.t: 973.808.0222e: eposillico@elusys.com

Excerpt from:

Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM, Its Treatment for Inhalation Anthrax, to the US Department of Health and Human Services...

The pandemic triggered the rise of mental health cases all around the world. It has been one of the most pressing concerns in the medical field, which is why experts have been trying to discover alternative and effective ways to treat mental healtha field where Sonia Singh is an expert.

Sonia Singh, LCSW, LCADC, popularly recognized by her trademarked name, The Happy Therapist, is a psychotherapist, as well as the founder of the Center of Inner Transformations, an alternative mental health and substance use treatment agency and wellness center that provides unique programming and services that address various psychological, emotional, and wellness needs. One of the Center of Inner Transformations premier programs includes the use of herbal and plant-based medications, also integrative evidence-based practices that have been researched, studied, and tested to be effective alternative solutions to treating mental health. Many of Ms. Sonia Singhs treatment methods are drawn from both modern and ancient, natural and holistic interventions that assist her clients in healing themselves with realistic and sustainable coping tools.

Plant-based health solutions and naturopathic healing has become a trend in recent years. Because of the rise of plant-based available foods and the advancement of public awareness campaigns about the long-term, harmful physiological effects of pharmaceutical medicines, people are more conscious of what they are consuming and how this affects their health. Traditional mental health treatments are very outdated and ineffective. Most mental health providers, me included, were initially trained with a strong foundation in modern, traditional mental health theories and treatment interventions. Much of which incorporates the use of pharmaceutical psycho-tropic medications, medication management, and related counseling. However, everything that a clinician learns after that traditional and ordinary training to help their clients overcome the issues that they present during their treatment is up to the perspectives of that clinician. Ive taken the path of focusing on what I call real wellness. This incorporates the use of natural elements and holistic mind, body, and spirit interventions to aid the mental and emotional healing process, says Ms. Sonia Singh, The Happy Therapist. People want long-term solutions. They want to change and transform their situations. They dont want to place a temporary band aid on their issues. They want real long-term change and they want to feel better.

Sonia Singh has focused the development of the Center of Inner Transformations to be a leader in alternative therapies, by including the use of plant-based medicines, supplements, and specific natural foods, plants and herbs, some of which may cause mild states of psychosis or euphoria. For certain mental health patients, primarily those people who struggle with a history of severe trauma or debilitating anxiety, natural alternatives are more desirable. They produce less to no negative long-term effects when used at an adult stage in life. The effects of a plant-based treatment protocol better corresponds with our bodies internal systems like a lock and key to aid healing. When we use natural elements from the earth as a part of our path to curing our health issues, we are giving ourselves life to live, Ms. Sonia Singh passionately states. My alternative programming provides choices. My clients choose which mind-altering substance they want to incorporate as a part of their treatment. Whether a psycho-tropic pharmaceutical medication or a plant-based medicine, supplement or wellness plan. They choose. The Center of Inner Transformations provides mental health interventions that may incorporate wellness treatment planning that focuses on harm reduction while combining holistic intervention and plant-based foods and medicines.

Ms. Sonia Singh is first-generation American-Punjabi, New York City native, and New Jersey resident who began her psychotherapeutic career in New Jersey close to her Alma Mater at Rutgers University. She directs several psychological and addiction treatment programs and has developed a line of wellness products and services that support her agencys mission to incorporate nature and holistic based treatment options.

The Center of Inner Transformations is a leading alternative mental health and substance use treatment agency that aims to address the opioid epidemic by influencing a culture that addresses their mental health concerns with naturopathic, holistic and safe treatment methods.

Media ContactCompany Name: Center of Inner TransformationsContact Person: Sonia SinghEmail: Send EmailPhone: (732) 508-0052Country: United StatesWebsite: http://www.centerofinnertransformations.com

Read this article:

Plant-Based Psychosis Inducing Alternative Mental Health Treatments Introduced by The Happy Therapist Sonia Singh - Digital Journal

A high blood pressure diet does not have to entail eating bland foods. Turning to Eastern culture, scientists have discovered a powerful bean which reduces the activity of angiotensin-converting enzyme (ACE) that constricts blood vessels resulting in high blood pressure.

Mung beans are tiny, oval-shaped beans are available in several forms, with the peeled version popular in Indian dishes, and the processed version of bean sprouts and starch noodles more common in Asian cuisine.

In a study published in the journal Human and Experimental Toxicology, scientists discovered that mung beans are highly effective at inhibiting LDL oxidation due to their potent free-radical scavenging properties.

The versatile mung bean has also been shown to target another significant cardiovascular disease risk factor in high blood pressure.

Hypertensive rats supplemented with mung bean sprout extracts for one month experienced significant reductions in systolic blood pressure.

Mung beans have a high concentration of phenols and protein fragments called peptides which help to reduce the activity of angiotensin-converting enzyme (ACE) that constricts blood vessels resulting in high blood pressure.

Recent studies involving 58,000 men and women aged 40-79 found that those with the lowest intakes of dietary magnesium had a 51 percent increased risk of heart disease mortality compared to those with the highest intakes.

Mung beans significantly improve magnesium levels and help to prevent heart attacks and damaging strokes.

Other studies highlight the benefits of mung beans for both hypertension and LDL cholesterol reduction.

Another study reported in the journal BMC Complementary and Alternative Medicine showed that mung beans suppress the growth of liver and highly aggressive cervical cancer lines.

This was done through multiple mechanisms, including cytotoxicity, inducing anti-cancer cytokines, halting cancer cell cycle, and triggering apoptosis.

These beneficial modes of action might be responsible for mung beans protection against other cancers as well.

See the article here:

High blood pressure: The tiny bean which relaxes blood vessels to help lower hypertension - Express

DUBLIN--(BUSINESS WIRE)--The "Complementary And Alternative Medicine For Anti Aging & Longevity Market Size, Share & Trends Analysis Report by Intervention (Botanicals, Mind Healing), by Customer, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global complementary and alternative medicine for anti aging and longevity market size is expected to reach USD 182.9 billion by 2028. It is expected to expand at a CAGR of 22.2% from 2021 to 2028.

Growing household income in developed countries, acceptance of herbal and ayurvedic medicine, and increasing age-related diseases have majorly the market for complementary and alternative medicine (CAM) for anti aging and longevity.

In the traditional alternative medicine/botanicals intervention segment, Ayurveda led the market in 2020 as cosmetic market players are involved in the R&D of Ayurveda-based anti-aging cosmeceuticals. The mind healing segment is expected to witness steady growth from 2021 to 2028 due to the rising acceptance of meditation and mindfulness in corporate offices.

The sensory healing segment is expected to expand at a considerable CAGR over the forecast period due to the increasing popularity in hospitals and clinics. For instance, in October 2021, Spatial, an audio platform, partnered with HealthTune scientific and Catalyst by Wellstar to use sensory healing to reduce stress and anxiety of frontline healthcare workers.

Ayurveda is acknowledged as a medicine in 16 countries including Brazil, Switzerland, Hungary, Nepal, Bahrain, UAE, and Saudi Arabia. Whilst, some regions such as Romania, Hungary, Ontario, and Turkey regulate ayurvedic practices. In the U.K., it is a part of the National Health Policy.

Thus, increasing acceptance of ayurvedic medicine is expected to drive the complementary and alternative medicine market to a major extent. In addition, insurance coverage by public and private players is anticipated to fuel market growth.

COVID-19 has become a catalyst for the implementation of CAM therapies in day-to-day life. Owing to the pandemic, online yoga classes witnessed a 25% increase in enrollment level.

Similarly, in the COVID-19 pandemic, the demand for yoga equipment accelerated by154%. Key players and governing regulatory bodies are undertaking various strategic initiatives such as regional expansion to develop their presence in the market.

Complementary And Alternative Medicine For Anti Aging & Longevity Market Report Highlights

Key Topics Covered:

Chapter 1 Methodology And Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends, & Scope

3.1 Market Lineage Outlook

3.1.1 Parent Market Outlook

3.1.2 Related/Ancillary Market Outlook

3.2 Market Dynamic

3.2.1 Market Driver Analysis

3.2.1.1 Increasing aging population and related diseases

3.2.1.2 Increasing awareness of traditional medicines

3.2.1.3 Government Initiatives and Encouraging Regulation

3.2.2 Market Restraints

3.2.2.1 FDA and medically approved drugs for aging

3.2.2.2 Target anti-aging related diseases indirectly (not the primary solution)

3.2.3 Market Opportunity

3.2.3.1 Development of Meditation centers

3.2.4 Market Threat

3.2.4.1 Rising consumption of anti age cosmetics

3.3 Penetration and Growth Prospect Mapping for Test Type 2020 (USD Million)

3.4 COVID-19 Impact Analysis

3.5 Business Environment Analysis

3.5.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)

3.5.2 Porter's Five Forces Analysis

3.6 Pricing Analysis

3.7 Antiaging Medicine

3.7.1 Integrative Medicine

3.7.2 Holistic Medicine

3.7.3 Functional Medicine

3.7.4 Nutritional Therapy

3.7.5 Exercise Therapy

3.7.6 Mental Therapy

Chapter 4 Intervention Business Analysis

4.1 Complementary And Alternative Medicine Market for Antiaging and Longevity: Intervention Movement Analysis

4.2 Traditional Alternative Medicine/Botanicals

4.2.1 Global Traditional Alternative Medicine/Botanicals Market For Antiaging And Longevity Estimates And Forecast, 2017-2028 (USD Million)

4.2.2 Ayurveda

4.2.3 Naturopathic Medicine

4.2.4 Traditional Chinese Medicine

4.2.5 Zang Fu Theory

4.3 Body Healing

4.3.1 Global Body Healing Cam Market For Antiaging And Longevity Estimates And Forecast, 2017-2028 (USD Million)

4.3.2 Yoga

4.3.3 Acupuncture & Massage

4.3.4 Chiropractic

4.3.5 Qigong & Tai Chi

4.3.6 Kinesiology

4.3.7 Reflexology

4.3.8 Eurythmy

4.4 Mind Healing

4.4.1 Global Mind Healing Based Market For Antiaging And Longevity Estimates And Forecast, 2017-2028 (USD Million)

4.4.2 Meditation & Mindfulness

4.4.3 Relaxation

4.5 External Energy Healing

4.5.1 Global External Energy Healing Based Market For Antiaging And Longevity Estimates And Forecast, 2017-2028 (USD Million)

4.5.2 Magnetic & Electromagnetic Therapy

4.5.3 Chakra Healing

4.5.4 Reiki

4.6 Sensory Healing

4.6.1 Global Sensory Healing Based Market For Antiaging And Longevity Estimates And Forecast, 2017-2028 (USD Million)

4.6.2 Aromatherapy

4.6.3 Sound Healing

Chapter 5 Customers Business Analysis

5.1 Complementary And Alternative Medicine Market for Antiaging and Longevity: Customer Movement Analysis

5.2 High net worth (HNW) individuals

5.3 Very high net worth (VHNW) individuals

5.4 Ultra-High Net Worth (Uhnw) Individuals

Chapter 6 Regional Business Analysis

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/urnnks

More:

World Anti-Aging & Longevity Complementary and Alternative Medicine Market Report 2022 - ResearchAndMarkets.com - Business Wire

Ayurveda states that the five elements of earth, water, fire, air and space are present in everything, including the human body

Its not uncommon for people to turn to herbal remedies or alternative medicines if theyre feeling unwell or have an ache or pain.

But Ayurveda, which is one of the oldest healthcare practices in the world and originates in India, now has global influences, with many people following the ancient form as a way of relieving pain and promoting healing.

Ayur means Life and Veda means wisdom/journey/enlightenment - and it focuses on these key pillars:

When combining specific, tailored parts of these pillars, it is believed the practitioner will live a long and healthy life.

What is Ayurveda?

Ayurveda states that the five elements of earth, water, fire, air and space are present in everything, including the human body.

These forces - each have their own characteristics and tendencies - are believed to combine to create a unique blueprint for every individual.

Your Dosha is your unique blueprint, with the three main Doshas being Vata (space and air), Pitta (fire and water) and Kapha (water and earth).

It is believed that any of these elements can move out of balance depending on the individuals lifestyle, the season, location and diet, and are said to cause imbalance which then in turn leads to illness and disease.

Scarlett Woodford, 33, is an Ayurvedic practitioner from London who says that coaches will gently observe you and ask questions in order to determine your current Dosha type.

They will then tailor a suitable therapy plan that aims to bring you back into optimum health and alignment with nature, Scarlett added.

The practitioner said that Ayurveda takes everything into account and believes that nothing acts in isolation, with all bodily organs, tissues, systems, channels and mental activity being connected.

This is echoed by Karolina Raczynska, secretary of the Ayurvedic Professionals Association, who says people should find a practitioner who can assess the health of the patient and formulate advice which is always individual for each patient.

Does Ayurveda work?

At an Ayurvedic clinic, a coach might treat someone for conditions such as anxiety, diabetes, psoriasis, arthritis, depression, polycystic ovary syndrome and asthma.

The National Center for Complementary and Integrative Health adds: A few studies suggest that Ayurvedic preparations may reduce pain and increase function in people with osteoarthritis and help manage symptoms in people with type 2 diabetes, but most of these trials are small or not well-designed.

There is little scientific evidence on Ayurvedas value for other health issues. People should never replace proven conventional treatments or therapies with unproven alternatives.

In regards to Ayurveda and cancer, Scarlet said that with more severe conditions such as this, it is more about symptom management than disease reversal, with many people reaching beyond the realms of traditional medicine when faced with such a diagnosis.

She added that practices involved in Ayurveda, including meditation, the use of oils, and manual therapies are proven to have a soothing, calming effect on the mind and body.

Martin Ledwick, head information nurse at Cancer Research UK, said: There is no scientific evidence that Ayurvedic medicine is effective at treating cancer either on its own or alongside conventional treatment. We would not recommend using it instead of evidence-based, conventional medicine.

Some people may choose to use it to gain a sense of well-being alongside their conventional treatment, but we would always advise checking with your doctor before taking any alternative or complementary treatment like Ayurveda to make sure there are no known interactions with any of the conventional drugs or treatments you are receiving.

You can do anything from making small, seemingly minor changes to your daily routine

Addressing the question as to whether Ayurveda is as effective as more traditional and modern-day medicines, Scarlett said it is too difficult to say.

She said that different practitioners will offer different opinions, but in her personal experience the two can be used together.

My Ayurvedic teacher is a medical GP as well as an Ayurvedic coach, therefore the teachings I have are very unique, added Scarlett.

One point to highlight is that Ayurveda can largely work as a preventative treatment, offering 360 degree holistic suggestions that tackle the mind, body and spirit, whereas traditional medicine tends to treat the physical symptom presented by a client in that moment.

For those looking to use Ayurveda alongside more modern-day medicine, Scarlett said that every case is different and in the past she has advised clients who are already taking a prescribed medication to keep on taking it.

She said: Its not necessarily a good idea to think totally in extremes, especially for those who have been reliant on a certain medication for a long time.

Thats the great thing about Ayurveda, you can do anything from making small, seemingly minor changes to your daily routine, to undergoing quite a routine changing seasonal cleanse, Scarlett added.

Both Ayurveda and modern medicine can be extremely helpful depending on the complaint, and can even compliment each other, Scarlett said.

Continued here:

What is the alternative medicine Ayurveda and does it work? - NationalWorld

Acupuncture is an alternative medical treatment that involves inserting tiny needles into specific points on a persons body. This approach may treat certain pains and illnesses, with some experts stating it could help with irritable bowel syndrome.

Acupuncture aims to balance a persons energy. Some claim this can help boost a persons well-being, treat pain, and cure some illnesses.

Acupuncture originates from traditional Chinese medicine. Research suggests the practice is effective in treating certain types of pain.

However, the National Center for Complementary and Integrative Health states that there is limited evidence suggesting acupuncture effectively treats ailments other than pain.

This article looks at whether acupuncture can help with irritable bowel syndrome (IBS) symptoms.

IBS refers to a group of symptoms that occur together, the most common of which are:

Some people with the condition claim that acupuncture has been very useful in helping relieve IBS-related symptoms. However, others with IBS say it offers no relief from these symptoms.

One older 2010 study involving 230 people with IBS gave some participants acupuncture and others a sham treatment, or placebo acupuncture. The study also included a control group that received no treatment at all.

The researchers found no difference in results between those who received the acupuncture and those who received the placebo acupuncture.

However, both groups of participants experienced more symptom relief than the control group. This study may suggest that positive results from acupuncture are due to the placebo effect.

Acupuncture practitioners may debate this conclusion, arguing that there is no way to provide sham acupuncture. This is because the results of acupuncture are systemic and less dependent upon the exact location of the needle insertion.

They may also argue that any insertion of an acupuncture needle is acupuncture, so any results of sham acupuncture are the results of the practice itself. Therefore, concluding that these positive results are due to the placebo effect may be inaccurate and actually demonstrate that acupuncture works.

A 2014 review of several controlled trials concludes that acupuncture effectively treats IBS symptoms. The research showed that the practice helped ease symptoms such as abdominal pain, bloating, and the sensation of incomplete bowel movements.

The review authors added that there were some limitations within the review, meaning they could not recommend acupuncture as a first-line treatment for IBS. They also stated that there was no evidence of the long term benefits of acupuncture for individuals with this condition.

One 2017 study compared acupuncture with traditional Western medicines for treating diarrhea associated with IBS. The study divided 61 IBS patients into two groups. One group received abdominal acupuncture, and the other group received pinaverium bromide tablets.

The results showed that acupuncture was a more effective treatment than Western medication. It stated that acupuncture effectively relieved abdominal pain, bloating, diarrhea, poor stool output, and stool abnormalities.

Another 2020 study compared acupuncture with traditional medication: polyethylene glycol 4000, or pinaverium bromide. The study found that acupuncture was a more effective treatment for the symptoms of IBS than this medicine.

Acupuncture points are specific parts of the body where acupuncture practitioners place their needles.

Below are some acupuncture points that these practitioners may use when treating people with IBS.

Here are some other alternative treatments for people with IBS.

Hypnotherapy involves using hypnosis to treat specific symptoms or health conditions.

According to the International Foundation for Functional Gastrointestinal Disorders (IFFGD), several clinical studies have shown that the practice can effectively treat people with IBS.

The IFFGD states that hypnotherapy for IBS involves progressive relaxation, soothing imagery, and sensations that focus on the individuals symptoms. The organization adds that hypnotherapy has led to people experiencing improvements in well-being, quality of life, bloating, abdominal pain, constipation, and diarrhea.

Cognitive behavioral therapy (CBT) is a method of working with people to explore relationships between their thoughts, feelings, and behaviors. The approach looks at how these relationships affect a persons well-being.

IBS is a chronic condition that is difficult to treat. Psychological processes play a role in both the development and the maintenance of the disorder. Some studies have shown that CBT can help provide significant and long-lasting improvements to IBS symptoms.

Certain mental health issues, such as depression, anxiety, and somatic symptom disorder, can cause IBS or worsen its symptoms.

Therefore, people with IBS may wish to use relaxation techniques to help control some symptoms of IBS.

According to the IFFGD, some of the following relaxation techniques may help a person with this condition:

A persons diet can affect their IBS symptoms. Some foods may worsen these symptoms, so a person with the condition may wish to avoid them.

Common foods that may cause IBS issues include:

Healthcare experts may suggest the following changes to help with IBS:

A healthcare professional may also recommend using medicines to treat certain symptoms of IBS. The following medicines may treat IBS with diarrhea:

The following medicines may treat IBS with constipation:

Doctors may prescribe additional medications to treat any abdominal pain due to IBS:

Healthcare professionals may also recommend that a person with IBS takes probiotics. These feature live microorganisms, most commonly bacteria, that can benefit a persons health.

People can use probiotics to balance their intestinal flora, known as the gut microbiome. Probiotics can help digest food, destroy disease-causing cells, or produce vitamins.

Some studies show that probiotics can help improve the symptoms of IBS.

If a person believes they may have IBS, they should contact a doctor. A healthcare professional can offer a diagnosis and devise treatment strategies if necessary.

To diagnose IBS, doctors usually review symptoms, medical and family history, and perform a physical exam. Doctors may order blood or stool tests to rule out other health problems in some cases.

If a person already has IBS and they experience a sudden worsening of symptoms, they may also wish to consult a doctor.

An individual with IBS may wish to seek medical attention if they experience:

Acupuncture is a medical treatment that originates from traditional Chinese medicine. It involves inserting needles or applying pressure to certain points on the body.

IBS is a long term gastrointestinal disorder that can cause abdominal pain, diarrhea, constipation, and bloating.

Some evidence states acupuncture can help ease IBS symptoms, while some research also shows that this may be due to the placebo effect.

However, several medications are available to treat the varying symptoms of IBS.

A person can also use other approaches to treat IBS symptoms, such as hypnotherapy, CBT, relaxation techniques, and dietary changes.

Read the rest here:

Acupuncture for IBS: Efficacy and alternative treatment options - Medical News Today

Millions of Amercians struggle to get a good nights rest, and millions have tried one of the myriad items that promise a better nights sleep. An estimated 4% of U.S. adults aged 20 and over used prescription sleep aids in the past month, the CDC notes. And among Americans who use CBD, 42% say its to help with sleep and insomnia. But theres one thing that research shows works to promote better sleep, but you dont often hear about: a scent diffuser infused with lavender. (You can check out one of our $22 picks for a scent diffuser here, and youll find details on this and other picks below.)

Indeed, theres a growing body of research that suggests that smell might also play a profound role in helping us fall, and stay asleep, says Dr. Nathaniel Fletcher Watson, the director of the Harborview Sleep Clinic and past-president of the American Academy of Sleep Medicine. A study published in 2012 found that essential oils such as lavender can deter minor sleep disturbances, as well as reduce anxiety. And another study published in 2019 found that pleasant or neutral odors presented during sleep may have helped allay nightmares in patients suffering from PTSD.

Lavender, in particular, seems to be an effective scent. It can help with sleep, Dr. Namni Goel, a professor and director of adult chronobiology and sleep medicine, biological rhythms research laboratory, at Rush University, who has studied the topic, told MarketWatch Picks. Indeed, a 2015 study published in the Journal of Alternative and Complementary Medicine, as well as a 2016 study, found that lavender improved the quality of sleep and how rested people felt when they woke up. An analysis of multiple studies on sleep and lavender published in 2012 in the European Journal of Integrative Medicine found that lavender oil may be of small to moderate benefit for those with sleep issues. And a 2005 study at Wesleyan University revealed that sniffing lavender improved sleep quality. (Here are a variety of options for lavender essential oil for a diffuser from Amazon here.)

So what scent diffusers do pro reviewers love? Here are a few.

Quiet and affordable

$22

Multi-purpose

$48

Great looking and long lasting

$114 on Amazon

View original post here:

One thing you probably should be trying to help you get a better nights sleep but probably arent - MarketWatch